伊古调节了绝经后骨质疏松症患者的血miRNA:一项随机对照试验
Haifeng Chen1, Ruikun Zhang1, Guijin Li2
1The Third Clinical Medical College of Zhejiang Chinese Medical University, Zhejiang Chinese Medical University, Hangzhou, Zhejiang, China.
Frontiers in pharmacology
|November 21, 2024
概括
伊古 (YGD) 通过调节微RNAs (miRNAs) 来改善绝经后骨质疏松症 (PMOP). 抑制miR-133a-3p被确定为YGD的一个关键机制.
科学领域:
- 综合医学是一个整体医学.
- 分子生物学分子生物学
- 老年学是一门学科.
背景情况:
- 绝经后骨质疏松症 (PMOP) 是老年人群的重大健康问题.
- 之前的研究表明,伊古 (YGD) 可以改善骨矿物质密度 (BMD),但其机制尚不清楚.
- 了解YGD对微RNAs (miRNAs) 的影响对于治疗PMOP至关重要.
研究的目的:
- 在PMOP患者中调查YGD,miRNA和骨代谢之间的关系.
- 阐明YGD影响骨健康的分子机制.
- 为YGD作为PMOP治疗提供科学依据.
主要方法:
- 一个为期3个月的随机临床试验,涉及60名PMOP患者,比较YGD和对照组.
- 评估BMD,血miRNA水平,VAS,ALP,TRACP-5b和TCM综合征的得分.
- GEO数据库的生物信息分析和基因本体学 (GO) 和KEGG路径丰富分析.
主要成果:
- YGD治疗改善了BMD,VAS,ALP,TRACP-5b和TCM综合征的得分.
- 两组之间观察到82个miRNA的显著差异,其中miR-133a-3p被确定为关键调解者.
- 生物信息分析强调了激素反应,生长因子信号传递以及PI3K-Akt,FOXO和JAK-STAT通路的丰富.
结论:
- YGD证明了PMOP的治疗益处,改善了临床症状和骨循环.
- 抑制miR-133a-3p表达是YGD在PMOP中的骨代谢调节的主要机制.
- YGD通过多目标和多路径方法来调节骨代谢.
相关概念视频
01:28Menopause
138
Menopause, a natural biological process marking the end of a woman's fertility, typically occurs between the fifth and sixth decade of life. This phase is characterized by the exhaustion of the ovarian follicle pool, leading to less responsive ovaries despite the high levels of Follicle Stimulating Hormone (FSH) and Luteinizing Hormone (LH). The consequential decrease in estrogen production results in symptoms like hot flashes, heavy sweating, headaches, hair loss, muscle pains, vaginal...
138
01:40Bone Remodeling
38.1K
Bone remodeling is a continuous and balanced process of bone resorption by osteoclasts and bone formation by osteoblasts. In adults, it helps maintain bone mass and calcium homeostasis. While mechanical stress can stimulate turnover as part of the normal maintenance and reparative process, several hormones also regulate bone remodeling.
38.1K
01:29Bone Disorders
3.4K
Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
3.4K